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Distinct effects of ASD and ADHD symptoms
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Abstract
Background: Autism spectrum disorder (ASD) traits are continuously distributed throughout the population, and ASD
symptoms are also frequently observed in patients with attention-deficit/hyperactivity disorder (ADHD). Both ASD and
ADHD have been linked to alterations in reward-related neural processing. However, whether both symptom domains
interact and/or have distinct effects on reward processing in healthy and ADHD populations is currently unknown.
Methods: We examined how variance in ASD and ADHD symptoms in individuals with ADHD and healthy participants
was related to the behavioural and neural response to reward during a monetary incentive delay (MID) task. Participants
(mean age: 17.7 years, range: 10–28 years) from the NeuroIMAGE study with a confirmed diagnosis of ADHD (n = 136),
their unaffected siblings (n = 83), as well as healthy controls (n = 105) performed an MID task in a magnetic resonance
imaging (MRI) scanner. ASD and ADHD symptom scores were used as predictors of the neural response to reward
anticipation and reward receipt. Behavioural responses were modeled using linear mixed models; neural responses were
analysed using FMRIB’s Software Library (FSL) proprietary mixed effects analysis (FLAMEO).
Results: ASD and ADHD symptoms were associated with alterations in BOLD activity during reward anticipation, but
not reward receipt. Specifically, ASD scores were related to increased insular activity during reward anticipation across
the sample. No interaction was found between this effect and the presence of ADHD, suggesting that ASD symptoms
had no differential effect in ADHD and healthy populations. ADHD symptom scores were associated with reduced
dorsolateral prefrontal activity during reward anticipation. No interactions were found between the effects of ASD and
ADHD symptoms on reward processing.
Conclusions: Variance in ASD and ADHD symptoms separately influence neural processing during reward anticipation in
both individuals with (an increased risk of) ADHD and healthy participants. Our findings therefore suggest that both
symptom domains affect reward processing through distinct mechanisms, underscoring the importance of
multidimensional and multimodal assessment in psychiatry.
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Background
Autism spectrum disorder (ASD) is a prevalent neurode-
velopmental disorder characterized by social, communica-
tive and behavioural deficits [1]. ASD traits are continuously
distributed in the general population, with symptomatology
below the clinical threshold for diagnosis being relatively
common [2–4]. Research into the broader ASD-related
phenotype is especially relevant since ASD symptoms
are elevated in various clinical populations, particu-
larly in patients with attention-deficit/hyperactivity
disorder (ADHD).
ADHD, a neurodevelopmental disorder characterized by
inattentiveness and/or hyperactivity and impulsivity, has been
associated with high ASD comorbidity and elevated levels of
ASD symptoms compared to the general population [5–7].
The high levels of comorbidity of ADHD and ASD could
be due to a shared aetiology, and studies have indeed
shown psychopathological, neuropsychological, neuroimag-
ing and genetic overlap between the disorders [8–10]. How
the two symptom domains interact in their effects on
cognition, however, remains largely unknown.
One area where ASD and ADHD effects could interact
is during the processing of reward. Both disorders have
been linked to abnormalities in the frontal-striatal neural
circuits associated with reward processing; whether this
is the result of similar pathophysiological mechanisms is
unclear [7, 11]. Summarizing the literature, it appears that
ASD is related to abnormalities in the processing of cer-
tain types of reward rather than associated with a general
reward-processing deficit [11, 12]. The processing of social
and monetary reward has generally been associated with
diminished activity in fronto-striatal areas in ASD versus
control participants [13–17]; in contrast, some studies
have also reported ASD-related hyperactivity during
monetary reward processing in brain regions outside
the traditional reward circuit [18, 16]. Increased responses
to other types of reward (food cues, faces and images of
personal relevance) have also been observed in partic-
ipants with ASD in the insula [19, 18], amygdala [18]
and (pre)frontal cortex [16, 18]. Reduced motivation to
obtain social and monetary rewards [20] combined with
increased motivation to pursue personally relevant stimuli
could explain these bidirectional findings in ASD [16, 19].
In ADHD, both hypoactivity and hyperactivity in re-
ward circuits in response to reward have been re-
ported. The current consensus is that ADHD is
characterized by decreased striatal activation during re-
ward anticipation [21], but increased prefrontal and stri-
atal responses during reward receipt, compared to
typically developing controls [22–25].
Only a few neuroimaging studies on reward processing
to date have included participants with ASD and ADHD
[11, 26, 27]. In a study by Kohls and co-workers, par-
ticipants with ADHD displayed increased striatal and
prefrontal activation during receipt of monetary reward
(compared to control and ASD groups), whereas the pres-
ence of ASD was associated with striatal hypoactivity for
both monetary and social reward conditions, in line with
previous research in ADHD and ASD samples [11]. Chan-
tiluke and colleagues compared the association between
behavioural and neural responses related to temporal
discounting in ADHD, ASD, comorbid ADHD/ASD and
healthy controls. Besides shared abnormalities in all pa-
tient groups, they also found ASD-specific differences in
the insula, and cerebellar deviations partially shared be-
tween ADHD and comorbid participants [27]. A pharma-
cological study from the same lab showed that fluoxetine
(a selective serotonin reuptake inhibitor) had different ef-
fects on the neural signatures of reward reversal in ASD
and ADHD [26]. ASD-related hypoactivation of medial
prefrontal cortex (mPFC) under placebo was norma-
lized under fluoxetine conditions, whereas participants
with ADHD displayed mPFC activation similar to controls
under placebo but hypoactivation after taking fluoxetine. In
addition, both ASD and ADHD showed hypoactivation of
the precuneus during reward reversal under placebo condi-
tions compared to controls, suggesting that reward reversal
is associated with both common and dissociative neural ab-
normalities in ADHD and ASD [26].
The previous studies therefore suggest that ASD and
ADHD can have both shared and distinct effects on re-
ward processing. In addition, some evidence suggests that
the cognitive dysfunctions of comorbid ASD and ADHD
are not simply a combination of those of ADHD and
ASD, but can be qualitatively different and/or more severe
[8, 27, 28]. However, much is still unknown about the spe-
cific and combined effects of ASD and ADHD symptoms
on reward processes within the same study population.
Hence, in the current study, we investigated these effects
in a large well-described sample that included individuals
with ADHD, their unaffected siblings and healthy control
participants. Unaffected siblings were included as they are
known to present with increased ASD symptom levels com-
pared to healthy controls [29]. Reward processing was mea-
sured using functional magnetic resonance imaging (fMRI)
during a monetary incentive delay (MID) task, a commonly
used reward task that reliably elicits activity in reward cir-
cuits [30]. By measuring both ADHD and ASD dimension-
ally, we could systematically investigate the separate and
cumulative impact of both factors. With this approach, we
aimed to gain insight into both the effects of comorbid
ASD and ADHD symptoms in individuals with ADHD
and to improve our understanding of the impact of
ASD and ADHD traits in unaffected populations.
We expected that higher levels of ASD symptoms would
be associated with activity changes in fronto-striatal regions
and the insula during reward anticipation and receipt based
on previous studies [12–19, 26, 27]. In contrast, ADHD
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symptoms were expected to relate to decreased striatal acti-
vation during reward anticipation, and increased fronto-
striatal activation during reward receipt [11, 21].
Based on our analyses, we can report two main findings
in this article. First, we observed that participants with
more ASD symptoms showed increased activity in the
insula during reward anticipation. Second, we found
that higher ADHD symptom levels were associated with
decreased activity in the dorsolateral prefrontal cortex dur-
ing reward anticipation. We found no effects during re-
ward receipt or any interaction between the ADHD and
ASD effects.
Methods
Setup
The current investigation was conducted as part of the
Dutch multisite NeuroIMAGE project ([31], http://
www.neuroimage.nl/). The NeuroIMAGE study was
approved by the local ethics committee (CMO Regio
Arnhem – Nijmegen; 2008/163; ABR: NL23894.091.08).
For details on recruitment of participants and a descrip-
tion of all study procedures in NeuroIMAGE, see [31].
Critically, this cross-sectional study uses a subsample of
the dataset used in von Rhein and colleagues [32], in
which reward processing was compared between healthy
participants and participants with a clinical diagnosis of
ADHD (Additional file 1).
Monetary incentive delay task
Participants performed a monetary incentive delay (MID)
task while undergoing MRI [33]. Participants were
instructed to respond as quickly as possible to a target (a
white circle) by pressing a button. Responses were correct
when given within 270–500 ms after target onset; specific-
ally, the response window was adapted to approximate a
33 % hit rate. Although MID tasks typically use higher re-
ward probabilities, the current task design has been used
successfully in the past and has been shown to reliably en-
gage the fronto-striatal reward circuit [34–36]. Each cor-
rect response (“hit”) shortened the window by 20 ms while
each incorrect response (“miss”) increased it by 10 ms. Re-
sponse windows were adapted for reward and non-reward
conditions separately to equalize the amount of hits on
both trial types. Although this method minimized differ-
ences in hit rates between conditions, it did so at the cost
of losing hit rate as a useful index of behavioural perform-
ance. Behavioural outcome was therefore assessed using
the reaction times in the reward and non-reward condi-
tion. Targets were preceded by a cue (a filled square, dur-
ation: 3.5–8.5 s) with variable colour coding (green for
reward, red for no reward) that deterministically predicted
whether a reward could or could not be obtained on the
current trial. Reward consisted of 0.20 € per correct re-
sponse in the reward condition. The outcome of each trial
was displayed for 1650 ms after response. Trials were con-
cluded by a fixed inter-trial interval (the presentation of a
blank screen) of 500 ms. The timing between events was
not jittered. In total, the task consisted of 25 reward and
25 non-reward trials, supplemented by 25 null events. Null
events were trials with only a fixation cross and required
no response. Participants were given standardized instruc-
tions and performed a block of practice trials before start-
ing the task. Trial order was pseudo-randomized, and the
total duration of the experiment was 12 min. The experi-
ment concluded by showing the total amount of money
awarded on the screen; this reward was subsequently
transferred to the participant’s bank account.
Participant selection
MRI data for the MID task was available for 564 partici-
pants from NeuroIMAGE, which represented all Neuro-
IMAGE participants who had no MRI contraindications
and were willing to undergo MR scanning [31]. Here, par-
ticipants were included in the analyses if they either 1) had
a diagnosis of ADHD, 2) were unaffected siblings of par-
ticipants diagnosed with ADHD or 3) were unrelated and
unaffected control participants. Healthy participants with
siblings with ADHD were not included in the control
group. Participants suffering from acute psychiatric condi-
tions other than ADHD were excluded. Furthermore, par-
ticipants were excluded if technical problems occurred
during MRI or any scientifically or clinically relevant
incidental findings were observed. Additionally, partic-
ipants who displayed excessive movement (3 move-
ments of 4 mm or more) during MRI were excluded to
safeguard data quality. Only 1 participant was included with
more than 0 but less than 3 large movements; this par-
ticipant showed 1 such shift during MRI acquisition.
Participants excluded for excessive motion were gen-
erally younger, had a higher chance of being diagnosed
with ADHD and generally displayed higher Conners Hyper-
activity scores than included participants (Additional file 2).
Although removal of these participants from our analyses
could result in a slight bias, it is a practical reality that such
a subpopulation is not optimally suited for MRI studies,
and acquiring data of a quality sufficient for analysis was
considered more important. Behaviourally, any participant
with <5 correct responses in the reward or non-reward
condition was excluded to improve our statistical power to
detect differences. Participants excluded for this reason
tended to be younger; participants with ADHD were over-
represented in the excluded sample but excluded par-
ticipants with ADHD did not differ in ADHD or ASD
symptom scores (or other demographics besides age)
compared to included participants with ADHD (Additional
file 2). The small bias in the sample used for our analyses
that resulted from this exclusion procedure was again
preferred over including participants for whom the
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reward-related neural processes could not be estimated
satisfactorily. Finally, only participants were included
for whom complete CSBQ questionnaire data were
available. A complete exclusion flowchart can be found
in Additional file 1.
After this exclusion process, 136 participants with ADHD
(“ADHD”), 83 siblings (“SIBS”) and 105 healthy controls
(“CON”, total N = 324) were available for analysis (for
demographics, see Table 1). Participants with ADHD
were confirmed to have a clinical diagnosis of ADHD
(Additional file 3). A subset of the ADHD group also
had comorbid diagnoses of oppositional defiant disorder
or conduct disorder (ODD/CD) (n = 39). Participants had
no other diagnosis of any neurological disorder or learning
disability, were 10–28 years of age, had an IQ ≥70, had
no MRI contraindications, were confirmed to be off-
medication at the time of testing for at least 48 h and
were of European-Caucasian descent. Written informed
consent was obtained from all participants.
Children’s Social Behavior Questionnaire
ASD symptoms were measured with the Children’s Social
Behavior Questionnaire (CSBQ; [37]). The CSBQ was
developed to measure the whole spectrum of ASD, includ-
ing milder, subclinical symptoms, and includes items that
directly refer to the DSM-5 criteria for ASD as well as items
that measure additional symptoms associated with ASD
[38]. It consists of 49 items divided into 6 subscales. The
six subscales are (1) “Not Tuned” (deficits in tuning emo-
tions and behaviour to the current situation), (2) “Lack of
Social Interest” (reduced social interest, motivation and
reciprocity), (3) “Orientation Problems”, (problems with
orientation in space and time), (4) “Not Understanding”,
(problems with understanding social context), (5) “Stereo-
typic Behaviour”, (repetitive motor and sensory behaviour
and stereotypy) and (6) “Resistance to Change” (fear and re-
sistance to change). CSBQ items from subscales 2, 4, 5 and
6 refer directly to the clinical criteria for ASD from DSM-5;
subscales 1 and 3 instead index other impairments typically
associated with ASD but not specific to this disorder (e.g.
executive functioning deficits and social-disruptive be-
haviour) [39]. Items are scored by parents or legal
guardians on a three-point scale ranging from “does not
apply” via “occasionally applies” to “clearly or often ap-
plies”. Subscale scores are calculated by summing up the
scores of all contributing items. In this study, a composite
score was used of the four CSBQ subscales that target
Table 1 Participants in the current study
ADHD Siblings Control
N = 136 N = 83 N = 105
Mean ± SD Mean ± SD Mean ± SD Comparison*
Age (years) 17.71 ± 3.04 18.36 ± 3.78 17.18 ± 3.01 ADHD = SIBS + CON; SIBS > CON
IQ 98.40 ± 14.80 99.11 ± 14.00 107.77 ± 13.91 CON > (ADHD = SIBS)
Conners T Score (combined scales) 69.76 ± 12.92 47.73 ± 6.69 45.38 ± 4.52 ADHD > SIBS > CON
CSBQ ASD 10.56 ± 9.44 9.14 ± 10.10 3.43 ± 4.54 (ADHD = SIBS) > CON
CSBQ Lack of Social Interest 3.89 ± 4.35 3.27 ± 4.14 1.12 ± 2.12 (ADHD = SIBS) > CON
CSBQ Problems with Social Understanding 3.93 ± 3.80 3.36 ± 3.75 1.38 ± 2.12 (ADHD = SIBS) > CON
CSBQ Stereotypical Behaviour 1.43 ± 2.32 1.42 ± 2.23 0.45 ± 1.06 (ADHD = SIBS) > CON
CSBQ Resistance to Change 1.32 ± 1.65 1.10 ± 1.67 0.48 ± 1.01 (ADHD = SIBS) > CON
Reward Hit rate .361 ± 0.06 .360 ± 0.06 .362 ± 0.06 ADHD = SIBS = CON
No Reward Hit rate .335 ± 0.07 .333 ± 0.06 .335 ± 0.06 ADHD = SIBS = CON
RT Reward Hits (ms) 292 ± 38.02 284 ± 67.64 283 ± 66.45 ADHD = SIBS = CON
RT No Reward Hits (ms) 326 ± 54.12_ 314 ± 79.54 310 ± 75.86 ADHD = SIBS = CON
RT Reward Miss (ms) 294 ± 40.10 283 ± 64.40 283 ± 64.40 ADHD = SIBS = CON
RT No Reward Miss (ms) 331 ± 59.06 311 ± 73.36 309 ± 78.13 ADHD > CON, ADHD = SIBS, SIBS = CON
Adulta 49.3 % 44.6 % 39.0 % Equal**
Siteb 40 % 40 % 59 % Unequal**
Sex 69 % M 45 % M 45 % M Unequal**
SD standard deviation, ADHD participants with ADHD, SIBS unaffected siblings, CON unrelated control participants, M male.
*Comparisons were made using independent sample t tests at p < 0.05; **equality of the distributions across participant groups was tested using Pearson’s Chi
Square Tests at p < 0.05
aPercentage of participants aged 18 years or older
bPercentage of participants scanned in Amsterdam (the remainder was scanned in Nijmegen)
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deficits specific to ASD (CSBQASD, the sum of scores on
scales 2, 4, 5 and 6) to isolate the contribution of ASD
symptoms from those of other disorders.
Conners Parent Rating Scale
As an analog to the dimensional CSBQASD score, we used
the Conners Parents Rating Scale Revised-Long Version
(CPRS-R-L) [40, 41] as a dimensional index of ADHD se-
verity. Specifically, we used the combined raw score of the
ratings on the DSM inattentive and DSM hyperactive/im-
pulsive subscales as our measure of ADHD symptoms. In
addition, we investigated the individual impact of the sub-
scales by including their raw scores as separate regres-
sors in supplementary analyses (Additional file 4).
Medication status
Although all participants with ADHD were off medication
for at least 48 h before our measurements were taken, their
history of medication use was not equal. Permission was
sought from each participant to obtain pharmacy records
describing their lifetime stimulant use. No distinction was
made between different stimulant drugs. Permission could
not be obtained from 39 participants (17 ADHD; 7 SIBS;
15 CON). For all other participants, medication records
were acquired. Records confirmed that no control par-
ticipants had a history of stimulant use. A few unaffected
siblings had a history of stimulant use: 5 siblings had used
stimulants up to 2 years, whereas 3 had used stimulants
for more than 2 years. It is important to note that these
siblings were not on medication around the time of test-
ing. Amongst the 119 participants with ADHD, 102 had a
history of stimulant use (with 22 having used/using stimu-
lants for up to 2 years, and 80 having used/using stimu-
lants for more than 2 years). Fourteen participants with
ADHD were stimulant drug-naive.
Behavioural analysis of the MID
Reaction times (RT) for both reward and non-reward con-
ditions were transformed by a log10 transformation to con-
form to the equality of variance assumption. Trials with
responses faster than 100 ms were excluded. RT for Re-
ward and Non-Reward Hits were first compared across all
participants in a paired t test using SPSS (version 21, IBM
Corporation, Armonk, New York, USA). Subsequently, lin-
ear mixed models were run in SPSS to model the effects of
various factors on the RT for Reward Hits, Non-Reward
Hits and the Reward Hit–Non-Reward Hit RT difference.
Models included the relevant RT as its dependent variable
and used dimensional scores of ASD and ADHD symp-
toms and their interaction, age, sex, IQ and scan site as
fixed effects with Family ID (to control for familial ef-
fects) modeled as a random effect. The ASD × ADHD
interaction term was calculated as the element-wise multi-
plication of the centered ASD and ADHD variables.
Medication use (cumulative stimulant medication duration)
was added as an additional random effect in a separate
model that included data from all participants for
whom medication data was available. This model
served as a sensitivity analysis to investigate the influence
of medication usage.
MRI acquisition
Functional magnetic resonance imaging (fMRI) data was re-
corded at two separate scan sites using nearly identical ac-
quisition parameters. At the VU University in Amsterdam,
data was acquired on a 1.5 T Siemens Sonata scanner; at the
Donders Institute for Brain, Cognition and Behaviour in
Nijmegen, data was acquired on a 1.5 T Siemens Avanto
scanner (both: Siemens Medical, Erlangen, Germany).
Whole-brain T2*-weighted images were acquired using
an echo planar imaging (EPI) sequence (37 slices in Nij-
megen/38 slices in Amsterdam, repetition time = 2340 ms,
echo time = 40 ms, field of view = 224 × 224 mm, voxel
size = 3.5 × 3.5 × 3.0 mm, matrix = 64 × 64, slice thick-
ness = 3 mm, 17 % gap). Whole-brain T1-weighted
anatomical images were acquired at both sites using a
magnetization-prepared, rapid acquisition gradient echo
(MPRAGE) sequence (176 slices, repetition time = 2730 ms,
echo time = 2.95 ms, inversion time = 1000 ms, voxel
size = 1.0 × 1.0 × 1.0 mm, field of view = 256 mm). To
control for site effects in the neuroimaging data, ana-
lyses included scan site as a covariate of no interest.
MRI preprocessing
Functional and structural imaging data were preprocessed
and analysed using the FMRIB Software Library (FSL, ver-
sion 5 [42]). The first 5 functional volumes of each partici-
pant were discarded to allow for T1 equilibrium. All other
volumes were realigned to the first remaining volume to
correct for head motion. The resulting extended re-
alignment parameters plus the extracted time courses
of regions containing white matter and cerebral spinal
fluid were then used for nuisance regression. Subsequently,
images were spatially smoothed using a Gaussian kernel
with a full width at half maximum (FWHM) of 6 mm and
high-pass filtered at 0.001 Hz.
Functional images were spatially co-registered to their as-
sociated structural image using FSL FLIRT and normalized
to MNI152 standard space after first-level statistics had
been performed. Considering the wide age range of our
sample, we opted to register all participants’ brains to a
custom study template that was generated by averaging
all T1-scans of participants in the NeuroIMAGE study
(n = 787), with a resolution of 2 × 2 × 2 mm after tran-
sforming it non-linearly to MNI152 space with FSL
FNIRT. For each participant, a non-linear warp-field
for normalization from T1 to the custom template was
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calculated and subsequently applied. This procedure
minimized the bias towards adult brains and provided a
better brain registration for younger participants.
MRI first-level analysis
For every subject, statistical parametric maps were esti-
mated using a general linear model that included all rele-
vant features of the MID trials (FSL FEAT). Six regressors
of interest were included, containing the onsets for reward
cues, non-reward cues, reward hits, reward misses, non-
reward hits and non-reward misses, with all events mod-
eled with a duration of zero. In addition, six regressors of
no interest were included. These regressors modeled 1)
movement artifacts; 2,3) the onsets of target presentation
for reward and non-reward trials; and 4,5,6) the onsets for
the cue, target and outcome of error trials. Movement ar-
tifacts were head movements from one image to the next
that exceeded a threshold of 0.5 mm in any direction.
Event onset of these artifacts was set to 8 s before the
movement and all events of interest within this 8 s interval
were discarded [43]. Error trials were trials with premature
responses (RT <100 ms), too many responses (>1 button
press) or no response. All these regressors were modeled
including their temporal derivatives and subsequently con-
volved with a canonical hemodynamic response function
(HRF).
The first-level models of the MID task provided two con-
trasts of interest. The neural effect of reward anticipation
was obtained by contrasting BOLD activity evoked by re-
ward and non-reward cues (Reward Cue >Non-Reward
Cue). Reward outcome-related activity was quantified by
contrasting the effect of correct responses during reward
trials with that observed during non-reward trials ([Reward
Hit–Reward Miss] > [Non-Reward Hit–Non-Reward
Miss]). Estimated beta maps for both contrasts were
normalized to MNI152 standard space for each par-
ticipant for subsequent group comparisons.
MRI second-level analysis
Group-level analyses modeled neural activation across
the full sample of participants (thus including partici-
pants with ADHD, their siblings and control participants
in the same model). Second-level activation maps were cal-
culated with FSL FLAME using the normalized beta maps
from the first-level analyses. Neural responses during re-
ward anticipation and reward outcome were modeled sep-
arately at the second level and included the first-level
variance estimates to account for between-subject dif-
ferences in the quality of parameter estimation. The
second-level model included the participant-specific ASD
symptoms, ADHD symptoms, the ASD×ADHD interaction
(the element-wise multiplication of the previous two vari-
ables), age, sex, IQ, scan site and ODD/CD comorbidity as
explanatory variables (EVs). The factor Group (i.e. ADHD,
siblings or control) was only present as EV in post hoc sen-
sitivity analyses. Additional models including separate re-
gressors for ADHD hyperactive/impulsive and inattentive
symptoms were run as supplementary analyses (Additional
file 4). All EVs were demeaned (using the overall sample
mean) before inclusion. The second-level models were cal-
culated using the FSL FLAMEO command and included
automatic detection and de-weighting of outliers [44].
Statistical thresholding
All results reported were based on an initial uncorrected
voxel-level threshold of Z > 2.3, corrected for the whole
brain at the cluster level using p < 0.025 (FWE, corrected
for testing both reward anticipation and reward receipt).
Post hoc analyses of second-level MRI results
The mean time-series of each cluster that survived cluster-
level correction were extracted for each participant using
FSL for post hoc analyses in SPSS. In these analyses, results
were corrected for familiality (i.e. the non-independence of
data from participants belonging to the same family due to
shared genetic and environmental influences). Time-series
for each cluster were entered as the dependent variable in a
linear mixed model that included ASD symptoms, ADHD
symptoms, the ASD×ADHD interaction, age, site and sex
as fixed effects and Family ID as a random effect. Moreover,
this analysis was repeated for the subset of participants for
whom medication data was available, additionally including
their total stimulant use duration as a random effect to
control for the effect of medication use. This extra model
served as a sensitivity analysis to investigate whether
our findings were influenced by medication usage. Fi-
nally, the presence of interactions between any CSBQASD
or CPRS-R-L effect and experimental group (ADHD, SIBS
or CON) was checked by running separate models that in-
cluded Group and a CSBQASD by Group interaction in
addition to all previous fixed and random effects. These
models served to test whether the observed effects of ASD
and ADHD symptoms and the parameter estimates in the
regions under investigation differed in the three experi-
mental groups. Alpha was set at p = 0.05 for all post hoc
analyses.
Results
Demographics
Table 1 lists the demographics of the experimental sam-
ple. Participants with ADHD were of similar age compared
to their siblings and healthy controls (ADHD vs SIBS
t217 = 1.33, p = 0.186; ADHD vs CON t239 = 1.35, p = 0.179);
unaffected siblings were older than controls (SIBS vs CON,
t186 = 2.32, p = 0.022). IQ was similar in participants with
ADHD and their siblings (ADHD vs SIBS, t217 = 0.36,
p = 0.725), but was higher in controls than the two other
groups (CON vs ADHD, t239 = 5.04, p < 0.001; CON vs
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SIBS, t186 = 4.22, p < 0.001). Scores on the CPRS-R-L were
highest for ADHD, as expected (ADHD vs SIBS, t217=16.58,
p < 0.001; ADHD vs CON, t239 = 20.47, p < 0.001), but were
also elevated in siblings compared to controls (SIBS vs
CON, t186 = 2.75, p = 0.007). Finally, CSBQASD scores were
higher in the ADHD group and their siblings compared to
controls (ADHD vs CON, t239 = 7.73, p < 0.001; SIBS vs
CON, t186 = 4.79, p < 0.001), but not significantly different
between the former groups (ADHD vs SIBS, t217 = 1.03,
p = 0.305). In summary, participants with ADHD showed
on average the highest severity of both ADHD and ASD,
their unaffected siblings were similar to the ADHD group
in ASD but not ADHD severity, and the healthy controls
scored lowest on both ADHD and ASD dimensions.
Behavioural analysis of the MID task
Correct responses were faster for Reward versus Non-
Reward Hits (Reward Hit RT ± standard error of the
mean (SEM) = 287.41 ± 3.1 ms; Non-Reward Hit RT ±
SEM = 317.18 ± 3.8 ms; paired t test on the log trans-
formed data: t323 = −12.73, p < 0.001). Subsequent mixed
model analyses (controlling for age, IQ, sex, scan site, fa-
milial effects and ADHD×ASD interactions) showed no
significant association between the CSBQASD or CPRS-
R-L scores and any RT measure (Reward Hits RT, Non-
Reward Hits RT, or the RT difference between correct
Reward and Non-Reward trials, all p > 0.05). In summary,
although we found that reward trials showed the expected
speeding of responses for all participants, we found no
evidence that ASD or ADHD symptoms modulated the
behavioural response of our participants in the MID task.
fMRI analysis of reward anticipation
All fMRI analyses were controlled for effects of age, sex,
IQ, scan site and ODD/CD comorbidity. Reward antici-
pation (Reward Cue > Non-Reward Cue) was associated
with significant activation in a network of brain areas in-
cluding the ventral striatum, amygdala, insula, cingulate
cortex and visual areas (Fig. 1a, Additional file 5). Non-
reward anticipation (Non-Reward Cue > Reward Cue)
was related to stronger activity in the posterior cingulate
and bilateral inferior parietal cortex.
ASD scores were positively correlated with activity in
bilateral insula and the left superior frontal gyrus during
reward anticipation. However, only the association be-
tween left insula activity and ASD scores remained sig-
nificant after correction for familial non-independence
and medication use (Fig. 1b, Additional file 5). This ef-
fect persisted when restricting our analysis to partici-
pants below 18 years of age and was not significantly
different in adults and children (Additional file 6). More-
over, we found no significant effect of Group (ADHD,
siblings or controls) on left insula activity or on the effect
of ASD symptoms in the left insula (Additional file 7). In
contrast, ADHD symptoms were negatively correlated with
activity in posterior parietal and left dorsolateral prefrontal
cortex (dlPFC) during reward anticipation. This nega-
tive correlation remained significant in the dlPFC after
correction for familial non-independence and medication
use (Fig. 1c, Additional File 5). This effect of ADHD symp-
toms was significant in participants below and above the
age of 18 years when analysed separately and was not
significantly different in these age groups (Additional
file 6). No significant interactions between ASD and
ADHD effects on reward anticipation were found.
Again, we found no significant effect of Group on left
dlPFC activity or on the effect of ADHD symptoms in
the dlPFC (Additional file 7). Supplementary analyses
looking at the distinct impact of ADHD hyperactive/im-
pulsive and inattentive symptoms showed that the former
was associated with reduced parahippocampal and lingual
gyrus activity and the latter with reduced caudate activity
during reward anticipation (Additional file 4).
fMRI analysis of reward outcome
The neural response to reward outcome was investigated
using the contrast between Rewarded and Non-Rewarded
outcomes (Reward Hit-Miss > Non-Reward Hit-Miss).
Rewarded hits were associated with significantly stro-
nger activation than non-rewarded hits in the ventral
striatum, anterior cingulate and orbito-frontal cortex, pos-
terior cingulate and parietal cortex and posterior visual
areas (Fig. 2). Non-rewarded outcomes were not linked to
significant increases in activation compared to rewarded
outcomes. No significant associations were found between
ASD or ADHD scores and neural responses during reward
receipt. Supplementary analyses related to distinct effects
of ADHD hyperactive/impulsive and inattentive symp-
toms similarly did not result in significant findings.
Discussion
In this study, we present evidence that variation in ASD
and ADHD symptoms is related to specific changes in the
neural signatures of reward processing in patients with
ADHD, their unaffected siblings and healthy controls. We
found that ASD symptoms were positively related to left
insula activity during reward anticipation across the three
experimental groups. In contrast, ADHD symptoms were
negatively related to activity in left dlPFC during reward
anticipation. Both findings could not be explained by
effects of age or sex. No effects of either ASD or ADHD
were found during reward outcome.
Neural hyperactivity during the processing of reward
in ASD is not a common finding, but has been demon-
strated previously [19, 18, 16]. Our findings are in line
with previous findings by Cascio and colleagues, who
also found ASD-related hyperactivity in the insula dur-
ing reward anticipation [19]. Our results also match well
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with the proposed role of the insula in interoceptive and
motivational processes [45–47] and its theorized rele-
vance to decision-making and abnormal reward-seeking
behaviour [48]. Anatomical evidence suggests that ASD
is characterized by structural abnormalities in the insula
that could relate to heightened interoception, and/or a
more internally oriented focus [49, 50]. Taken together,
increased insula activity in individuals with higher levels
of ASD symptoms might be related to altered motiv-
ational processes and/or greater interoception. As such,
activity in the insula might be considered a possible marker
of cognitive dysfunction in milder forms of ASD.
ADHD symptoms were associated with reduced left
dlPFC activity during reward anticipation. ADHD has
previously been linked to hypoactivity during anticipa-
tion of monetary reward, although primarily in striatal
regions [21, 11, 51, 52]. Although the dlPFC is not consid-
ered a central part of the neural reward circuit, in our
study it was involved in reward anticipation (i.e. more
strongly activated during anticipation of reward versus
no reward across the sample). This finding would suggest
that the dlPFC is differentially responsive to rewarded
versus non-rewarded contexts. Furthermore, the dlPFC
has shown ADHD-related abnormalities in various cog-
nitive contexts, due to its proposed role in attentional and
motivational processes, and our finding could thus reflect
more general neurocognitive alterations associated with
ADHD [53–55]. In addition, exploratory analyses of the re-
ward anticipation phase using separate ADHD subscales
indicated that hyperactive/impulsive symptoms were
associated with reduced activity in the parahippocampal
and lingual gyrus, whereas inattentive symptoms were
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Fig. 1 Neural responses associated with reward anticipation. a Reward anticipation: activation stronger for Reward versus Non-Reward Cues. Activation
plotted represents the linear contrast between reward and non-reward cues from the time of cue onset. Reward anticipation was associated with stronger
response in a network of brain areas including the striatum, medial (pre)frontal cortex, bilateral insula and parahippocampus, as well as posterior occipital
and parietal regions. b ASD symptom scores were positively correlated with left insula activity during reward anticipation. c ADHD symptom scores were
negatively correlated with left dorsolateral prefrontal cortex activation during reward anticipation. All activation shown was initially thresholded at the voxel
level at Z> 2.3, followed by whole-brain correction at the voxel level at p< 0.025 (FWE). The clusters shown in panels b and c are significant after correction
for familial non-independence and medication use. Results are plotted on representative slices of the NeuroIMAGE study template brain; coordinates are
given in MNI space. See Additional file 5 for coordinates, p values and cluster extent. L left. P posterior. Z Z value
z = 0
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Fig. 2 Reward outcome: activation stronger for Rewarded versus
Non-Rewarded Outcomes. Activation plotted represents the linear
contrast (Reward Hit–Reward Miss) > (Non-Reward Hit–Non-Reward
Miss). Reward outcome was associated with increased activity in the
striatum, orbito-frontal and prefrontal cortex; bilateral posterior and
inferior parietal cortex; posterior, mid and anterior cingulate gyrus
and bilateral amygdala and hippocampus. No significant increases in
activation were observed for non-rewarded outcomes. All activation
shown was initially thresholded at the voxel level at Z > 2.3, followed
by whole-brain correction at the voxel level at p< 0.025 (FWE). Results are
plotted on representative slices of the NeuroIMAGE study template brain;
coordinates are given in MNI space. See Additional file 5 for coordinates,
p values and cluster extent. Z Z value
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linked to reduced caudate activity. These findings pro-
vide initial evidence that these subscales might modulate the
neural response to reward anticipation differentially.
Against expectation, we found no evidence for striatal ef-
fects of ASD symptoms in our study. Although striatal defi-
cits related to reward processing have been observed in
multiple ASD studies [51], other studies did not find striatal
abnormalities in monetary reward conditions [13, 14, 56].
We can only speculate about the reasons why striatal func-
tioning was unaffected by ASD symptoms in our study.
Our large sample size provided enough power to de-
tect effects. Instead, differences in task parameters (e.g. di-
mensional measures versus categorical definitions of ASD;
differences in reward probability and amount of reward)
could provide an explanation. In addition, striatal abnor-
malities might be characteristic of clinical ASD only, and
not clearly apparent in less affected populations. Note that
we did find that the ventral striatum and other areas of
the frontal-striatal reward circuit were robustly activated
during reward anticipation and receipt, in line with other
studies, indicating that our task manipulation was success-
ful [57, 30].
We did not find evidence for effects of ASD or ADHD
symptoms during reward receipt, in the outcome phase of
the MID task. Although it is difficult to speculate about the
reasons for a null-finding, it could be in part due to the
lower number of trials available for the outcome condition.
However, we believe that our large sample offers substantial
protection against this potential problem, and we do find
strong reliable reward outcome-related neural responses. It
could nevertheless be that dimensional effects of ADHD
and ASD during the reward outcome phase are smaller
than those during reward anticipation.
In addition to the expected positive effects of reward
anticipation in fronto-striatal regions, we also observed
significant activation differences in the reversed contrast
(i.e. stronger activity for anticipation of no reward versus
reward). These effects were localized in brain areas previ-
ously associated with the so-called default mode network
and could therefore reflect reduced task engagement (and
increased mind-wandering) during non-reward versus re-
ward anticipation [58].
The results of this study should be seen in the context of
some strengths and limitations. First, although a large part
of the autistic spectrum was covered in our experiment due
to the inclusion of three groups of participants with varying
degrees of ASD symptoms, we did not measure the ex-
treme end of the spectrum by including participants with a
clinical diagnosis of ASD. This makes it difficult to translate
our findings to more severely affected populations. How-
ever, our results remain relevant for individuals with ADHD
and the general population, where milder forms of ASD are
commonly observed. To extend our findings and provide
converging evidence for the results of the current study, we
are currently conducting research using participants
with a clinical diagnosis of ASD who are also evalu-
ated for ADHD symptomatology in the EU-AIMS pro-
ject (www.eu-aims.eu).
We did not find behavioural effects of ASD or ADHD on
the MID task in this study. We can therefore only speculate
on the behavioural relevance of the current findings. Never-
theless, the absence of behavioural effects also erases a po-
tential confound for the interpretation of the neuroimaging
findings, and suggests that both ASD and ADHD symp-
toms are affecting the neural substrates of reward process-
ing in a way that cannot simply be explained by differences
in behaviour. This notwithstanding, the direct clinical rele-
vance of our findings is not immediately apparent and will
require future study.
An important strength of the current study was the use
of dimensional measures of ADHD and ASD symptoms.
These measures allowed for a more refined analytic ap-
proach relative to traditional categorical comparisons be-
tween populations. Similar approaches are becoming more
and more common in psychiatry, as the relevance of di-
mensional aspects of many psychiatric disorders becomes
increasingly apparent [59, 60]. Future studies in ASD and
ADHD populations could therefore benefit from including
similar designs to further disentangle the contribution of
ASD and ADHD symptoms to reward processes.
Unfortunately, this study could not investigate whether
ASD (and ADHD) symptoms affect social (and other types
of) reward differently from monetary reward. Further re-
search is needed to investigate the specificity of our find-
ings. Follow-up research could clarify whether social
reward paradigms show similar effects. Given the on-
going discussion about the special relevance of social
reward deficits in ASD and ADHD, such studies could
provide valuable novel insights [20, 9].
Since data were available from participants with
ADHD (who scored high on ADHD and ASD), their un-
affected siblings (who scored high on ASD but not ADHD)
and healthy controls (who scored low on ADHD and ASD),
our sample included a wide range of ASD and ADHD
symptoms. This design, in combination with our large sam-
ple size, enabled us to separate effects of ADHD and ASD
and study whether both symptom dimensions interacted.
We found no evidence for an interaction between ADHD
and ASD symptom scores, nor did we find that the neural
effects of ASD and ADHD symptoms differed in the three
experimental groups. Our findings therefore suggest that
ASD and ADHD symptoms affected all types of partic-
ipants equally (at a given level of severity) and that
ASD and ADHD did not have multiplicative effects in
our sample. Practically, this would mean that ASD and
ADHD affect reward processing in distinct ways and via
different (neural) mechanisms. Our findings thus do not
directly support theories of a shared aetiology between
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ASD- and ADHD-related reward dysfunction, nor do they
point towards a qualitative difference in reward abnormal-
ities in individuals who score high on both ASD and
ADHD symptom measures. However, our sample did not
include individuals with clinical levels of both ADHD and
ASD, so we cannot rule out that such individuals would
show specific abnormalities in line with previous studies
[8, 27, 28].
Conclusions
With this study, we provide evidence that variation in
ASD- and ADHD-related symptomatology can modu-
late the neural response to reward anticipation in par-
ticipants with ADHD, their unaffected siblings and healthy
controls. Taken together, these results underscore the im-
portance of multidimensional assessment for clinical and
healthy populations in general and for the characterization
of ADHD- and ASD-related effects on reward process-
ing in particular.
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